Balloon Valvuloplasty Device Market Introduction
Balloon valvuloplasty is a common method to treat valve stenosis. Stenosis is the contraction of an opening such as the heart valve. Balloon valvuloplasty, also known as valvuloplasty or balloon valvotomy, is a procedure to repair the heart valve that has a narrowed opening. Balloon valvuloplasty improves blood flow through the valve and treats symptoms. During valvuloplasty, a thin, long tube known as catheter with a balloon on the tip is inserted into the artery of the patient’s arm or groin. It is then guided into the narrowed valve of the heart using the x-ray machine. The balloon is inflated, which enlarges the opening of the valve and separates the leaflets. The balloon is then deflated and both, the balloon and the catheter, are removed.
Global Balloon Valvuloplasty Device Market- Competitive Landscape
Boston Scientific Corporation
Founded in 1979, Boston Scientific Corporation is headquartered in Marlborough, the U.S. The company develops, manufactures, and markets medical devices used in an extensive range of interventional procedures worldwide. The company is among the leading providers of minimally invasive devices used for the treatment and diagnosis of gastrointestinal diseases. Moreover, it holds a leading position in the spinal cord stimulation devices sector in the U.S. Boston Scientific Corporation has production plants in 12 countries and offices in approximately 40 countries across the globe.
To Know More about TMRs Unique Offerings for Balloon Valvuloplasty Device Market, Request a Brochure here
Established in 1921, Terumo Corporation is headquartered in Tokyo, Japan. It is a leading player in the fields of minimally invasive entry site management, lesion access, and interventional technologies. Terumo Corporation operates through a strong network of subsidiaries located in the U.K., Russia, the U.S., Europe, and China. Terumo Corporation operates through three major business segments: Cardiac & Vascular Company, General Hospital Company, and Blood Management Company.
Incorporated in 1958, Edwards Lifesciences is headquartered in California, the U.S. It is a medical equipment company specializing in manufacturing hemodynamic monitoring devices and artificial heart valves. The company partners with clinicians to develop advanced technologies in the fields of critical care monitoring and structural heart disease to help patients. The company manufactures products in several global locations, including Puerto Rico, the U.S., the Dominican Republic, and Singapore.
Global Balloon Valvuloplasty Device Market Dynamics
Increase in Number of Heart Related Conditions to Drive Global Balloon Valvuloplasty Device Market
Rise in the number of heart related conditions across the globe is a key factor driving the balloon valvuloplasty device market. According to the European Society of Cardiology, prevalence and incidences of rheumatic heart disease (RHD) differ significantly among regions and age groups. The global prevalence of rheumatic heart disease is approximately 1 per 1,000 in children aged between 5 years and 14 years. Additionally, the World Health Organization states that the rheumatic heart disease mostly affects children in developing countries. Worldwide, approximately 2% of deaths that occur due to cardiovascular diseases are related to RHD.
Looking for Customized Insights to build your Business for Future, Ask for a Custom Report here
Asia Pacific is Rapidly Expanding Region of Balloon Valvuloplasty Devices
The balloon valvuloplasty device market in Asia Pacific is expected to expand at a faster rate during the forecast period due to factors such as increase in disposable income of consumers, rise in prevalence of heart valve diseases, and improvement in the health care infrastructure. However, North America is expected to dominate the global balloon valvuloplasty device market during the forecast period owing to high number of patients afflicted with cardiovascular diseases and availability of well-established reimbursement policies in countries such as the U.S.
Global Balloon Valvuloplasty Device Market– Segmentation
The global balloon valvuloplasty device market can be divided based on:
Global Balloon Valvuloplasty Device Market Segmentation – by Product
In terms of Product, the global balloon valvuloplasty device market can be classified into:
- 23 mm
- 26 mm
- 29 mm
Global Balloon Valvuloplasty Device Market Segmentation – by End-user
Based on end-user, the global balloon valvuloplasty device market can be segmented into:
- Ambulatory Surgical Centers
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.